BridgeMD
Fluid administration in ketoacidosis
EU CTIS ID: 2024-511513-37-00
What this study is testing
To compare fluid resuscitation with Ringer Lactate to isotonic saline on the resolution of diabetic ketoacidosis at 24 hours from randomization (i.e. start of the investigational medicinal product administration) in patients with severe diabetic ketoacidosis.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Admission to emergency department or direct admission to ICU
- Diagnosis of severe diabetic ketoacidosis requiring all the following criteria: o Blood or capillary glucose > 11 mmol/L o Ketonemia or ketonuria > 0 o Venous or arterial pH < 7.30 or venous or arterial bicarbonate < 15 mmol/L
- Volume of fluid administered before inclusion ≤1L
You likely can't join if
- Patients <18 ans
- Pregnant women
- Contraindication to isotonic saline or Ringer Lactate
- Patients with a decision to withdraw life-sustaining therapy
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.